Evoke Pharma - 53 Year Dividend History | EVOK

Historical dividend payout and yield for Evoke Pharma (EVOK) since 1972. The current TTM dividend payout for Evoke Pharma (EVOK) as of June 11, 2025 is $0.00. The current dividend yield for Evoke Pharma as of June 11, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.010B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.175B 7.21
Dr Reddy's Laboratories (RDY) India $13.265B 24.08
BridgeBio Pharma (BBIO) United States $7.612B 0.00
Bausch Health Cos (BHC) Canada $1.887B 1.36
Supernus Pharmaceuticals (SUPN) United States $1.862B 15.12
Amphastar Pharmaceuticals (AMPH) United States $1.269B 8.52
Taysha Gene Therapies (TSHA) United States $0.560B 0.00
Personalis (PSNL) United States $0.488B 0.00
Assembly Biosciences (ASMB) United States $0.132B 0.00
Sol-Gel Technologies (SLGL) Israel $0.019B 0.00
Teligent (TLGT) United States $0.000B 0.00